Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Posner

Showing results (171-180 of 247) with videos related to

Pageof 25
Sort By:
American Journal of Clinical Oncology|August 3, 2005
Organ preservation and treatment toxicity with induction chemotherapy followed by radiation therapy or chemoradiation for advanced laryngeal cancerBeverly A Guadagnolo, Robert I Haddad, Marshall R Posner, et al.
Archives of Otolaryngology (Chicago, Ill. : 1960)|April 1, 1984
Advanced squamous carcinoma of the head and neck. A preliminary report of neoadjuvant chemotherapy with cisplatin, bleomycin, and methotrexateT J Ervin, R R Weichselbaum, R L Fabian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013
Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer groupPierre Blanchard, Jean Bourhis, Benjamin Lacas, et al.
Cancer Treatment Reports|October 1, 1986
Cisplatin administered as a continuous 5-day infusion: plasma platinum levels and urine platinum excretionJ F Belliveau, M R Posner, L Ferrari, et al.
Journal of the National Cancer Institute|November 29, 2007
Lack of association of alcohol and tobacco with HPV16-associated head and neck cancerKatie M Applebaum, C Sloane Furniss, Ariana Zeka, et al.
Frontiers in Oncology|September 12, 2022
The Sinai Robotic Surgery Trial in HPV-related oropharyngeal squamous cell carcinoma (SIRS 2.0 trial) - study protocol for a phase II non-randomized non-inferiority trialRaymond L Chai, Rocco M Ferrandino, Christine Barron, et al.
Oral Oncology|November 24, 2020
Human papillomavirus genotype distribution in head and neck cancer: Informing developing strategies for cancer prevention, diagnosis, treatment and surveillanceS S Mashiana, P Navale, B Khandakar, et al.
The Oncologist|February 27, 2003
Docetaxel, cisplatin, 5-fluorouracil (TPF)-based induction chemotherapy for head and neck cancer and the case for sequential, combined-modality treatmentRobert Haddad, Roy B Tishler, Charles M Norris, et al.
International Journal of Radiation Oncology, Biology, Physics|May 3, 2011
Treatment of oral cavity squamous cell carcinoma with adjuvant or definitive intensity-modulated radiation therapyDavid J Sher, Vijaya Thotakura, Tracy A Balboni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 20, 2012
Treatment of oropharyngeal squamous cell carcinoma with IMRT: patterns of failure after concurrent chemoradiotherapy and sequential therapyD J Sher, V Thotakura, T A Balboni, et al.
Pageof 25

Showing results (171-180 of 247) with videos related to

Sort By:
Pageof 25
American Journal of Clinical Oncology|August 3, 2005
Organ preservation and treatment toxicity with induction chemotherapy followed by radiation therapy or chemoradiation for advanced laryngeal cancerBeverly A Guadagnolo, Robert I Haddad, Marshall R Posner, et al.
Archives of Otolaryngology (Chicago, Ill. : 1960)|April 1, 1984
Advanced squamous carcinoma of the head and neck. A preliminary report of neoadjuvant chemotherapy with cisplatin, bleomycin, and methotrexateT J Ervin, R R Weichselbaum, R L Fabian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013
Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer groupPierre Blanchard, Jean Bourhis, Benjamin Lacas, et al.
Cancer Treatment Reports|October 1, 1986
Cisplatin administered as a continuous 5-day infusion: plasma platinum levels and urine platinum excretionJ F Belliveau, M R Posner, L Ferrari, et al.
Journal of the National Cancer Institute|November 29, 2007
Lack of association of alcohol and tobacco with HPV16-associated head and neck cancerKatie M Applebaum, C Sloane Furniss, Ariana Zeka, et al.
Frontiers in Oncology|September 12, 2022
The Sinai Robotic Surgery Trial in HPV-related oropharyngeal squamous cell carcinoma (SIRS 2.0 trial) - study protocol for a phase II non-randomized non-inferiority trialRaymond L Chai, Rocco M Ferrandino, Christine Barron, et al.
Oral Oncology|November 24, 2020
Human papillomavirus genotype distribution in head and neck cancer: Informing developing strategies for cancer prevention, diagnosis, treatment and surveillanceS S Mashiana, P Navale, B Khandakar, et al.
The Oncologist|February 27, 2003
Docetaxel, cisplatin, 5-fluorouracil (TPF)-based induction chemotherapy for head and neck cancer and the case for sequential, combined-modality treatmentRobert Haddad, Roy B Tishler, Charles M Norris, et al.
International Journal of Radiation Oncology, Biology, Physics|May 3, 2011
Treatment of oral cavity squamous cell carcinoma with adjuvant or definitive intensity-modulated radiation therapyDavid J Sher, Vijaya Thotakura, Tracy A Balboni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 20, 2012
Treatment of oropharyngeal squamous cell carcinoma with IMRT: patterns of failure after concurrent chemoradiotherapy and sequential therapyD J Sher, V Thotakura, T A Balboni, et al.
Pageof 25